TIMP3 and diabetic retinopathy: In an in vivo and in vitro study on diabetic retinopathy, a decrease in TIMP3 expression was accompanied by an increase in oxidative stress injury, which was manifested by an increase in ROS and a decrease in SOD and CAT enzyme activities.